Global Antimicrobial Susceptibility Tester Market Size By Type (Automatic Antimicrobial Susceptibility Tester, Manual Antimicrobial Susceptibility Tester), By Application (Hospital, Clinic), By Region...

The Global Antimicrobial Susceptibility Tester Market was valued at USD 3.1 billion in 2023 and is projected to reach USD 5.4 billion by 2031, growing at a CAGR of 7.2% during the forecast period (2023–2031). The increasing prevalence of antimicrobial-resistant infections, rising demand for effective diagnostics in clinical microbiology, and government initiatives promoting antimicrobial stewardship programs are driving the market. Antimicrobial susceptibility testers are essential in identifying the most effective treatment against pathogens, thereby supporting optimized patient care and reducing inappropriate antibiotic usage.

Drivers:

1. Rising Incidence of Antimicrobial Resistance (AMR):

Global health authorities have identified AMR as a growing threat, prompting healthcare facilities to invest in advanced diagnostic tools. Antimicrobial susceptibility testers (AST) are critical for identifying resistant strains and guiding targeted treatment.

2. Increasing Healthcare Expenditure and Diagnostic Awareness:

Governments and private entities are enhancing investments in healthcare infrastructure and diagnostic capabilities. This includes equipping hospitals and diagnostic labs with state-of-the-art AST devices.

3. Technological Advancements in AST Systems:

The evolution of rapid automated systems and molecular diagnostics has significantly reduced result turnaround times. These innovations support precise detection, improve workflow, and are accelerating market growth.

Restraints:

1. High Cost of Advanced AST Equipment:

The adoption of automated and high-throughput AST systems can be expensive, particularly for low-resource settings. Initial investment and maintenance costs may hinder market expansion in developing regions.

2. Lack of Skilled Laboratory Personnel:

Proper interpretation of susceptibility results requires trained microbiologists. The global shortage of skilled professionals poses a challenge, especially in rural and underfunded healthcare environments.

Opportunity:

1. Emerging Markets and Decentralized Testing Expansion:

Increasing demand for infectious disease diagnostics in Asia-Pacific, Africa, and Latin America presents substantial opportunities. Portable and point-of-care AST systems are gaining traction in these regions.

2. Integration with AI and Lab Automation:

Advancements in AI-based predictive analytics and lab automation systems are opening new avenues for AST integration, improving test accuracy and laboratory efficiency.

Market by System Type Insights:

In 2023, the Automated AST systems segment held the largest market share due to their ability to process large volumes of samples with high accuracy and minimal human intervention. This segment is expected to witness the highest growth during the forecast period, driven by the adoption of high-throughput laboratory systems in hospitals and reference laboratories.

Market by End-use Insights:

The Hospital & Diagnostic Laboratories segment dominated the market in 2023, accounting for over 45% of the total revenue. The increasing patient inflow, prevalence of hospital-acquired infections, and reliance on evidence-based treatments have led to widespread adoption of AST systems in this segment. Research laboratories are also expected to grow steadily with the rising focus on novel antibiotic development.

Market by Regional Insights:

North America was the leading region in 2023, driven by strong healthcare infrastructure, high awareness about AMR, and support from public health agencies like the CDC and FDA. However, Asia-Pacific is anticipated to register the fastest growth through 2031 due to expanding healthcare access, rising infectious disease burden, and strategic governmental investments in diagnostic technology.

Competitive Scenario:

Key players in the Global Antimicrobial Susceptibility Tester Market include bioMérieux SA, Thermo Fisher Scientific Inc., Becton, Dickinson and Company (BD), Danaher Corporation, Merck KGaA, Liofilchem Srl, Accelerate Diagnostics, Inc., HiMedia Laboratories, Bio-Rad Laboratories, Inc., and Creative Diagnostics. These companies focus on developing rapid diagnostic platforms, expanding geographical reach, and entering strategic partnerships to solidify their presence.

Scope of Work – Global Antimicrobial Susceptibility Tester Market

Report Metric Details

Market Size (2023) USD 3.1 Billion

Projected Market Size (2031) USD 5.4 Billion

CAGR (2023–2031)